Reports for AMPHASTAR PHARMACEUTICALS, INC.
Company Name
AMPHASTAR PHARMACEUTICALS, INC.
Totals |
||
Shortage reports |
7 |
|
Actual shortage: | 1 (14%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 6 (86%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
2 (29%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
BAQSIMI | 3MG | POWDER | Resolved | 2024-02-22 | 2024-02-28 | 220276 |
BAQSIMI | 3MG | POWDER | Resolved | 2024-08-20 | 2024-09-23 | 235530 |
BAQSIMI | 3MG | POWDER | Actual shortage | 2024-10-10 | 2024-10-11 | 239831 |
CORTROSYN INJ 0.25MG | 0.25MG | POWDER FOR SOLUTION | Resolved | 2018-01-17 | 2018-04-04 | 36165 |
CORTROSYN INJ 0.25MG | 0.25MG | POWDER FOR SOLUTION | Resolved | 2021-10-22 | 2022-01-19 | 147831 |
CORTROSYN INJ 0.25MG | 0.25MG | POWDER FOR SOLUTION | Resolved | 2022-02-11 | 2022-04-30 | 154776 |
CORTROSYN INJ 0.25MG | 0.25MG | POWDER FOR SOLUTION | Resolved | 2022-05-20 | 2022-06-28 | 161043 |
Showing 1 to 7 of 7
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0